IL-21 expression during sublingual immunotherapy for allergic rhinitis
American Journal of Clinical and Experimental Immunology · 2026 · 15 (2) · 142-147
DOI: 10.62347/xbrn4628 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical and Experimental Immunology, 2026. Verfasst von Chunrui Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, The 1st Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang, The People's Republic of China. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology, The 1st Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang, The People's Republic of China.
Zitieren
APA
Wang, C., Qin, X., Jiang, L., & Zhang, T. (2026). IL-21 expression during sublingual immunotherapy for allergic rhinitis. American Journal of Clinical and Experimental Immunology, 15(2), 142-147. https://doi.org/10.62347/xbrn4628
Vancouver
Wang C, Qin X, Jiang L, Zhang T. IL-21 expression during sublingual immunotherapy for allergic rhinitis. American Journal of Clinical and Experimental Immunology. 2026;15(2):142-147. doi:10.62347/xbrn4628
BibTeX
@article{Wang2026,
author = {Wang, Chunrui and Qin, Xiaowei and Jiang, Li and Zhang, Tianhong},
title = {IL-21 expression during sublingual immunotherapy for allergic rhinitis},
journal = {American Journal of Clinical and Experimental Immunology},
year = {2026},
volume = {15},
number = {2},
pages = {142--147},
doi = {10.62347/xbrn4628}
}
EUVIMED